Daré Bioscience, Inc. (DARE)
NASDAQ: DARE · IEX Real-Time Price · USD
0.316
+0.021 (7.15%)
Apr 23, 2024, 10:33 AM EDT - Market open
Daré Bioscience Market Cap
Daré Bioscience has a market cap or net worth of $31.56 million as of April 23, 2024. Its market cap has decreased by -63.72% in one year.
Market Cap
31.56M
Enterprise Value
19.47M
1-Year Change
-63.72%
Ranking
Category
Stock Price
$0.32
Market Cap Chart
Since April 10, 2014, Daré Bioscience's market cap has decreased from $98.00M to $31.56M, a decrease of -67.79%. That is a compound annual growth rate of -10.67%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Apr 22, 2024 | 29.70M | 5.32% |
Apr 19, 2024 | 28.20M | -5.05% |
Apr 18, 2024 | 29.70M | 4.21% |
Apr 17, 2024 | 28.50M | -41.60% |
Apr 16, 2024 | 48.80M | 1.04% |
Apr 15, 2024 | 48.30M | 2.33% |
Apr 12, 2024 | 47.20M | -2.68% |
Apr 11, 2024 | 48.50M | 0.62% |
Apr 10, 2024 | 48.20M | 1.69% |
Apr 9, 2024 | 47.40M | -5.58% |
Apr 8, 2024 | 50.20M | 1.62% |
Apr 5, 2024 | 49.40M | -3.52% |
Apr 4, 2024 | 51.20M | 5.79% |
Apr 3, 2024 | 48.40M | -2.22% |
Apr 2, 2024 | 49.50M | -0.60% |
Apr 1, 2024 | 49.80M | 1.01% |
Mar 28, 2024 | 49.30M | -8.87% |
Mar 27, 2024 | 54.10M | 10.18% |
Mar 26, 2024 | 49.10M | -3.35% |
Mar 25, 2024 | 50.80M | 7.86% |
Mar 22, 2024 | 47.10M | 0.64% |
Mar 21, 2024 | 46.80M | 2.63% |
Mar 20, 2024 | 45.60M | -9.34% |
Mar 19, 2024 | 50.30M | - |
Mar 18, 2024 | 50.30M | 9.11% |
View and export this data all the way back to 2014.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Acurx Pharmaceuticals | 29.08M |
Aprea Therapeutics | 29.05M |
Eyenovia | 28.88M |
Spruce Biosciences | 28.82M |
Addex Therapeutics | 28.79M |
Lipocine | 28.01M |
Qilian International Holding Group | 27.89M |
Lexaria Bioscience | 27.23M |